IMIDAZOIMIDAZOLES AND TRIAZOLES AS ANTI-INFLAMMATORY AGENTS
申请人:Boehringer Ingelheim Pharmaceuticals Inc.
公开号:EP1216247B1
公开(公告)日:2008-11-05
US7517897B2
申请人:——
公开号:US7517897B2
公开(公告)日:2009-04-14
US7550494B2
申请人:——
公开号:US7550494B2
公开(公告)日:2009-06-23
DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a] IMIDAZOLE-3-SULFONIC ACID
申请人:Barry Patrick John
公开号:US20060264472A1
公开(公告)日:2006-11-23
Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.